In conclusion, our findings suggest that the Hb/Cr ratio may represent a simple yet informative marker of increased risk in STEMI patients, capturing the combined burden of anemia and renal dysfunction—two conditions that, even when mild, appear to synergistically worsen prognoses. This evidence concerns the gene GSTM1 and Abnormal renal physiology.